AMCP Responds to Senate Approval of Drug Quality & Security Act
AMCP released a statement in response to Senate passage of the Drug Quality and Security Act, a bill that would enhance the security of drug distribution and create a new entity in statute for the compounding of drugs.
AMCP Monthly Webinar Series
Join us this December for two very exciting Webinars! On Dec. 11 we will cover AMCP advocacy efforts, and on Dec. 18 we will take a look at the AMCP eDossier System. Check out our calendar of events for all future Webinars and events.
URAC/AMCP Quality Management News and Information for Pharmacy Released
The Fall 2013, Issue 3 edition of the URAC AMCP quarterly e-newsletter, in collaboration with URAC and AMCP to provide quality management and news for the managed care pharmacy industry.
NEW - AMCP Nexus 2013 Photos Available!
Check out many of our photos and a brief video gallery from AMCP's Nexus 2013 Conference in San Antonio, TX. Experience this great conference once again!
AMCP – Celebrating 25 Years!
To celebrate its 25th anniversary, AMCP has captured the recollections of key individuals who had the foresight to create the Academy two-and-a-half decades ago, as well as some current and upcoming leaders who are the beneficiaries of their vision.
AMCP 2013 Guide to Pharmaceutical Payment Methods
The AMCP Guide to Pharmaceutical Payment Methods, 2013 Update (Version 3.0) is a comprehensive, factual description and analysis of alternative drug payment methods and payment benchmarks.
Comparative Effectiveness of Hypoglycemic Medications Among Veterans
The efficacy of diabetic medications among patients with multiple comorbidities is not tested in randomized clinical studies. It is important to monitor the performance of these medications after marketing approvals...
Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 Diabetes
Diabetes prevalence is increasing in the United States, yet the control of critical clinical metrics (e.g., hemoglobin A1c [A1c],blood pressure, and lipids) remains suboptimal. Lower A1c levels ...
A Systematic Review of the Economic and Humanistic Burden of Illness in Irritable Bowel Syndrome and Chronic Constipation
Irritable bowel syndrome (IBS) and chronic constipation (CC) are common functional gastrointestinal disorders affecting 14% and 20% of the U.S. population, respectively. Reviews of the evidence on the burden of illness associated with IBS and CC...
The Impact of Manufacturer Coupon Use in the Statin Market
Pharmaceutical manufacturer coupons are a rapidly growing promotional activity intended to encourage initiation and continuing use of brand-name medications, but little is known about impacts on medication adherence and expenditures.
Benefit Restrictions and Gout Treatment
Gout is a chronic rheumatic disease that can have serious sequelae, including persistent pain, nerve compression, joint destruction and deformities if left untreated...
Effects on Patient Care Caused by Drug Shortages: A Survey
Drug shortages pose a serious challenge for health care institutions, often interfering with patient care. A common practice during a drug shortage is to select an alternate therapeutic; however, these agents...